A Study on Safety and Efficacy of Tocilizumab (RoActemra/Actemra) Alone or in Combination With Non-Biologic Antirheumatics in Participants With Rheumatoid Arthritis
PHASE3
This multi-center, open-label single arm Phase IIIb study will evaluate the...
A Study of Tocilizumab in Participants With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Non-Biological Disease-modifying Anti-rheumatic Drugs (DMARDs)
N/A
This observational study will evaluate the safety and efficacy of tocilizum...
National Data Bank for Rheumatic Disease Registry Study of Safety in Patients With Rheumatoid Arthritis Treated With Cimzia® or Disease-modifying Antirheumatic Drugs (DMARDs)
N/A
Observational registry to assess the longer-term risk of serious infections...
Status
Completed
Location
Multiple Locations
Start Date
2009-09-01
Trial ID
NCT01095393
A Study of Subcutaneous Tocilizumab as Monotherapy and/or in Combination With Non-Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs) in Participants With Rheumatoid Arthritis
PHASE3
This Phase IIIb, multicenter, open label, single arm study will evaluate th...
Status
Completed
Location
District Gen. Hosp. of Athens Laiko; A Propedeutic Internal Medicine Clinic & Research Center
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug (DMARD)
PHASE3
This study includes two periods. The main objective of Period 1 is to compa...
Study Conducted in Subjects With Rheumatoid Arthritis Who Have Moderate to Severe Disease Activity Despite Methotrexate Therapy With or Without Other Non Biologic Disease Modifying Antirheumatic Drugs (DMARDs)for at Least 12 Weeks Prior to Screening
PHASE4
To compare the maintenance of efficacy of the combination of etanercept 50 ...
Status
Completed
Location
Hospital Santa Izabel - Santa Casa de Misericórdia da Bahia